Waldencast Acquisition Corp. (WALD) Adds $8M PIPE to OBAGI and Milk Deal
by Marlena Haddad on 2022-06-15 at 6:05pm

Waldencast Acquisition Corp. (NASDAQ:WALD) announced this afternoon that it has increased its PIPE by $8 million and entered into a conditional consent in regards to its combination with beauty brands OBAGI and Milk Makeup.

On June 14, Waldencast entered into subscription agreements with certain investors that have collectively subscribed for 800,000 shares of common stock for an aggregate purchase price equal to $8 million, bringing the total PIPE investment to $112 million. Waldencast originally brought about $345 million into the deal from its current trust alongside a $105 million PIPE and $333 million in forward purchase agreements (FPAs) at deal announcement. Waldencast’s sponsor and affiliates are funding $160 million of the FPAs with $173 million more coming form third parties.

Conditions to Obagi’s obligation to consummate the merger include that Waldencast receives at least $50 million in cash and the Obagi Cash Consideration equaling or exceeding $327.5 million, subject to reduction for Obagi’s expense overage. Milk’s closing conditions, on the other hand, includes that Waldencast receives, after completion of the transactions contemplated by the Milk Equity Purchase Agreement, at least $50 million and the Milk Cash Consideration is at least $112.5 million.

On June 13, Waldencast also entered into a conditional consent with Obagi and Cedarwalk pertaining to the value of and cost associated with inventory on hand. As of five business days before the special shareholder meeting, the cost of inventory will be deducted from the cash portion of the consideration payable under the Obagi merger agreement to Cedarwalk.

Obagi Hong Kong will pay Obagi and certain affiliates a royalty of 2.75% of gross sales on the specific inventory identified in the consent that is sold during the 90 days following the completion of the transaction.

Waldencast initially announced the $1.2 billion combination with OBAGI and Milk Makeup on November 15. OBAGI provides medical-grade skincare products and Milk Makeup provides clean 100% vegan cosmetics via retail stores and its native ecommerce site.



Recent Posts
by Kristi Marvin on 2023-09-29 at 5:48pm

Athena Consumer Acquisition Corp. (NYSE:ACAQ) announced this afternoon that its stockholders approved its combination with German EV-maker e.GO at a special meeting held earlier today. Additionally, Athena Consumer’s warrant proposal to convert all outstanding warrants to 0.175 shares in the combined company was also approved. A total of 884,880 shares of Athena Class A Common...

by Nicholas Alan Clayton on 2023-09-29 at 4:28pm

October is set to be a quiet month for lock-up expirations with only four de-SPACs and four sponsors now open to trade their shares for the first time. The first customer is Bitdeer Technologies. Its shareholders and the Blue Safari sponsor both stand to gain the most out of this group from moving some of...

by Nicholas Alan Clayton on 2023-09-29 at 3:51pm

Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that its shareholders approved its combination with NKGen Biotech at a special meeting September 25. A total of 3,386,528 shares were redeemed in connection with the vote, leaving Graf IV with about $27.6 million in the tank and a final redemption rate of 84.3%....

by Nicholas Alan Clayton on 2023-09-29 at 3:50pm

Anzu Special Acquisition Corp I (NASDAQ:ANZU) has closed its combination with Envoy Medical and its shares and warrants are to begin trading on the Nasdaq under the symbols “COCH” and “COCHW” on October 2. The SPAC secured shareholder approval on September 27 and still has not divulged redemption figures. But, it went into the vote...

by Nicholas Alan Clayton on 2023-09-29 at 1:54pm

Mercato Partners (NASDAQ:MPRA) closed its combination with Brazilian software firm Nuvini this afternoon and its shares and warrants are expected to begin trading on the Nasdaq under the symbols “NVNI” and “NVNIW” on October 2. The combined company will continue to be led by its existing CEO and a seven-member Board including Mercato CEO Dr....


Copyright © 2023 SPACInsider, Inc. All Rights Reserved